• 제목/요약/키워드: Confidence Value

검색결과 926건 처리시간 0.024초

어묵의 소비기한 설정을 위한 보관방법 별 어묵의 품질변화 연구 (A study on the quality change of fish cakes by storage conditions to set the use by date of fish cakes)

  • 황선혜;김민주;최지연;조용선
    • 분석과학
    • /
    • 제35권6호
    • /
    • pp.267-273
    • /
    • 2022
  • 본 연구에서는 어묵의 유통기한을 소비기한으로 변경하기 위해 품질평가를 진행하였다. 제품 품질 평가를 위해 보관 조건은 5, 10, 15 ℃로 설정하고 pH, 산가, 휘발성염기질소, 세균수, 대장균군 등 5가지 항목에 대한 실험을 진행하였다. 실험결과 어묵의 품질유지한계기간은 5 ℃에서 43일, 10 ℃에서 30일, 15 ℃에서 7일이었다. 품질평가에 사용된 5가지 시험항목 중 품질한계지표가 있는 항목은 산가, 세균수, 대장균군이었다. 그리고 3가지 보관조건에서 품질유지한계기간을 결정하는 지표는 세균수였다. 본 실험에 사용된 어묵의 유통기한은 10일이나 품질평가를 통해 10 ℃에서의 소비기한은 28.5일로, 품질유지한계기간인 30일에 안전계수 0.95를 곱한 값이다. 그러나 본 연구는 1개 업체의 어묵 1품목에 대한 품질평가를 수행하였기에, 본 연구에서 설정한 품질유지한계기간 및 소비기한을 보편적으로 사용하기에는 무리가 있다. 유통기한을 소비기한으로 변경하기 위해서는 다양한 제품에 대한 광범위한 품질 연구가 필요하다. 이 제도가 잘 갖춰진다면 올바른 음식물 섭취를 통해 음식물폐기물을 줄이는 데 도움이 될 수 있고, 소비자들은 안심하고 식품을 섭취할 수 있다.

새우류 중금속 저감에 대한 전체가구의 효용 추정 (Estimation of Overall Household Utility for Heavy Metal Reduction in Shrimp)

  • 진현정;위예진
    • 한국식품위생안전성학회지
    • /
    • 제38권4호
    • /
    • pp.255-263
    • /
    • 2023
  • 갑각류 중금속 기준은 납과 카드뮴의 경우 각각 0.5 mg/kg과 1.0 mg/kg 이하이다. 비소, 수은, 메틸수은 및 주석은 현재 노출 수준을 고려하여 지속적인 오염도를 조사하고 있다. 이를 기반으로 정부에서는 노출 점유율, 검출률, 오염도가 높은 다소비 식품 목록을 공유하여 수입·유통검사에 활용하고 있다. 새우류는 연안의 유기물질이 많이 포함된 모래나 진흙질, 해조가 많은 곳, 하구 등에 서식하기 때문에 잠재적으로 중금속에 노출될 가능성이 큰 것으로 알려져 있다. 본 연구에서는 새우류 중 특정 중금속의 기준치를 초과하는 품목 그리고 기준치가 없는 경우 검출치 최상위 품목을 판매에서 제외하는 경우 소비자 불안 감소 및 안심도 제고의 화폐적 가치를 측정하였다. 가상가치평가법을 이용하여 소비자 지불의사를 도출하였는데, 질문방식은 개방형직접질문과 지불카드방식을 이용하였다. 도출된 지불의사를 국내 가구 수에 접목하여 총효용을 추정한 결과, 363.9억 원으로 나타났다. 본 연구의 결과는 수산물 중금속에 대한 특정 정책이 소비자의 불안감 감소와 심리적인 안심감을 어느 정도 제고시켜주는지에 대한 실증분석 결과를 제공한다. 이는 식품 안전성이 높아지고 중금속으로 인한 질병에 걸릴 확률이 감소하는 것에 대해서 소비자가 느끼는 가치를 제시해준다.

ANP기법을 이용한 교통시설 건설사업의 편익항목 선정에 관한 연구 (The Study on Determination of Benefit Factor as Constructing Traffic Facilities Using ANP)

  • 김만경;정헌영;이상용
    • 대한토목학회논문집
    • /
    • 제26권1D호
    • /
    • pp.41-47
    • /
    • 2006
  • 교통시설 건설사업을 기획하고 평가하는 단계에서 형평성 및 효율성에 많은 논란이 제기되고 있는 사업들이 존재하고 있다. 그 이유 중의 하나는, 사업의 타당성을 평가함에 있어서 소요되는 비용은 명백히 드러나지만 사업실시에 따른 편익항목의 종류와 기준은 애매모호한 부분이 존재하기 때문이다. 이에 본 연구에서는 편익항목을 설정하는 기준을 명확히 하기 위하여 우선적으로, 부산광역시의 도로 및 도시철도의 시설이용자에 대한 만족도 평가와 함께 교통시설에 있어 기존의 경제성 분석방법으로 평가를 실시하였다. 그 결과 이용자들은 도시철도 이용에 대한 만족감이 도로이용보다는 높게 나타났으나 경제성 분석 방법인 B/C분석을 행한 결과, 도시철도시설이 대상도로에 비해 경제적 타당성이 상당히 낮은 것으로 나타났다. 이와 같은 모순적인 사실은 현재 부산광역시의 인구에 대비한 지하철 수단분담율에 비춰볼 때 편익항목에 대한 설정 기준이 맞지 않아 편익의 값이 다소 적게 산출된 결과라고 판단할 수 있다. 따라서 본 연구에서는 교통시설 건설타당성 평가를 실시할 경우에 고려되어야 할 편익항목들을 열거하고 ANP기법을 통하여 각각의 항목에 대한 가중치를 산정하였다. 그 결과 접근성, 정시성, 주행시간 순으로 높은 가중치를 가지고 있었으며, 기존의 경제성 분석시 고려되는 편익항목보다는 주민의 교통여건향상에 따른 편익항목이 더욱 높은 중요도를 가지고 있는 것을 알 수 있었다.

노인의 자원봉사활동 참여 동기가 자기확장성에 미치는 영향: 자기효능감의 매개효과를 중심으로 (The Effect of Senior Citizens' Motivation to Participate in Volunteer Activities on Self-Expansion: Based on the Median Effect of Self-Effect)

  • 최장원
    • 한국노년학
    • /
    • 제39권2호
    • /
    • pp.241-259
    • /
    • 2019
  • 본 연구는 노인 자원봉사활동의 성과를 성공적 노화나 생산적 노화가 아닌 노인의 자기효능감과 자기확장성의 관점에서 연구하고자 하였다. 이를 통해 노년기에 일어날 수 있는 내적성장과 자가의 확장을 검증 할 수 있으며, 노년기 삶을 재조명하는 계기를 마련하는데 연구의 목적이 있다. 이러한 연구목적을 검증하기 위하여 부산광역시의 시청 및 구청에서 진행하는 자원봉사활동에 참여한 노인 300명을 연구대상으로 하여, 2018년 9월부터 11월까지 약 3개월에 걸쳐 설문지를 배부하여 불성실하게 응답되었다고 판단된 34부의 설문지를 제외한 후 266부의 자료를 본 연구에 사용하였다. 연구결과는 다음과 같다. 첫째, 노인의 자원봉사활동참여 동기(가치기능, 사회기능, 이해기능)는 자기효능감에 긍정적인 영향을 미치는 것으로 나타났다. 둘째, 자원봉사활동참여 동기(가치기능, 사회기능, 이해기능)는 자기확장성에 긍정적인 영향을 미치는 것으로 나타났다. 셋째, 노인의 자기효능감(자기조절 효능감, 자신감)은 자기확장성에 긍정적인 영향을 미치는 것으로 나타났다. 넷째, 자기효능감((자기조절 효능감, 자신감)은 노인의 자원봉사활동 참여동기와 자기확장성의 관계에서 매개효과가 발생하는 것으로 나타났다. 본 연구는 노인의 자원봉사활동 참여동기가 자기효능감과 자기확장성에 영향을 미친다는 관련성을 규명 하였다. 특히, 노인에게 심리사회적 개념인 자기효능감의 매개변수를 활용하여, 노인복지의연구의 새로운 관점을 제공함으로써 향후 노인의 자원봉사활동 활성화를 위한 실천적, 정책적 방안을 제시하였다는데 연구의 의의가 있다.

Diagnostic value of serum procalcitonin and C-reactive protein in discriminating between bacterial and nonbacterial colitis: a retrospective study

  • Jae Yong Lee;So Yeon Lee;Yoo Jin Lee;Jin Wook Lee;Jeong Seok Kim;Ju Yup Lee;Byoung Kuk Jang;Woo Jin Chung;Kwang Bum Cho;Jae Seok Hwang
    • Journal of Yeungnam Medical Science
    • /
    • 제40권4호
    • /
    • pp.388-393
    • /
    • 2023
  • Background: Differentiating between bacterial and nonbacterial colitis remains a challenge. We aimed to evaluate the value of serum procalcitonin (PCT) and C-reactive protein (CRP) in differentiating between bacterial and nonbacterial colitis. Methods: Adult patients with three or more episodes of watery diarrhea and colitis symptoms within 14 days of a hospital visit were eligible for this study. The patients' stool pathogen polymerase chain reaction (PCR) testing results, serum PCT levels, and serum CRP levels were analyzed retrospectively. Patients were divided into bacterial and nonbacterial colitis groups according to their PCR. The laboratory data were compared between the two groups. The area under the receiver operating characteristic curve (AUC) was used to evaluate diagnostic accuracy. Results: In total, 636 patients were included; 186 in the bacterial colitis group and 450 in the nonbacterial colitis group. In the bacterial colitis group, Clostridium perfringens was the commonest pathogen (n=70), followed by Clostridium difficile toxin B (n=60). The AUC for PCT and CRP was 0.557 and 0.567, respectively, indicating poor discrimination. The sensitivity and specificity for diagnosing bacterial colitis were 54.8% and 52.6% for PCT, and 52.2% and 54.2% for CRP, respectively. Combining PCT and CRP measurements did not increase the discrimination performance (AUC, 0.522; 95% confidence interval, 0.474-0.571). Conclusion: Neither PCT nor CRP helped discriminate bacterial colitis from nonbacterial colitis.

Development and Validation of a Prognostic Nomogram Based on Clinical and CT Features for Adverse Outcome Prediction in Patients with COVID-19

  • Yingyan Zheng;Anling Xiao;Xiangrong Yu;Yajing Zhao;Yiping Lu;Xuanxuan Li;Nan Mei;Dejun She;Dongdong Wang;Daoying Geng;Bo Yin
    • Korean Journal of Radiology
    • /
    • 제21권8호
    • /
    • pp.1007-1017
    • /
    • 2020
  • Objective: The purpose of our study was to investigate the predictive abilities of clinical and computed tomography (CT) features for outcome prediction in patients with coronavirus disease (COVID-19). Materials and Methods: The clinical and CT data of 238 patients with laboratory-confirmed COVID-19 in our two hospitals were retrospectively analyzed. One hundred sixty-six patients (103 males; age 43.8 ± 12.3 years) were allocated in the training cohort and 72 patients (38 males; age 45.1 ± 15.8 years) from another independent hospital were assigned in the validation cohort. The primary composite endpoint was admission to an intensive care unit, use of mechanical ventilation, or death. Univariate and multivariate Cox proportional hazard analyses were performed to identify independent predictors. A nomogram was constructed based on the combination of clinical and CT features, and its prognostic performance was externally tested in the validation group. The predictive value of the combined model was compared with models built on the clinical and radiological attributes alone. Results: Overall, 35 infected patients (21.1%) in the training cohort and 10 patients (13.9%) in the validation cohort experienced adverse outcomes. Underlying comorbidity (hazard ratio [HR], 3.35; 95% confidence interval [CI], 1.67-6.71; p < 0.001), lymphocyte count (HR, 0.12; 95% CI, 0.04-0.38; p < 0.001) and crazy-paving sign (HR, 2.15; 95% CI, 1.03-4.48; p = 0.042) were the independent factors. The nomogram displayed a concordance index (C-index) of 0.82 (95% CI, 0.76-0.88), and its prognostic value was confirmed in the validation cohort with a C-index of 0.89 (95% CI, 0.82-0.96). The combined model provided the best performance over the clinical or radiological model (p < 0.050). Conclusion: Underlying comorbidity, lymphocyte count and crazy-paving sign were independent predictors of adverse outcomes. The prognostic nomogram based on the combination of clinical and CT features could be a useful tool for predicting adverse outcomes of patients with COVID-19.

Implications of Sarcopenia and Glucometabolism Parameters of Muscle Derived From Baseline and End-of-Treatment 18F-FDG PET/CT in Diffuse Large B-Cell Lymphoma

  • Xiaoyue Tan;Xiaolin Sun;Yang Chen;Fanghu Wang;Yuxiang Shang;Qing Zhang;Hui Yuan;Lei Jiang
    • Korean Journal of Radiology
    • /
    • 제25권3호
    • /
    • pp.277-288
    • /
    • 2024
  • Objective: We previously found that the incidence of sarcopenia increased with declining glucose metabolism of muscle in patients with treatment-naïve diffuse large B-cell lymphoma (DLBCL). This study aimed to investigate the relationship between sarcopenia and muscle glucometabolism using 18F-FDG PET/CT at baseline and end-of-treatment, analyze the changes in these parameters through treatment, and assess their prognostic values. Materials and Methods: The records of 103 patients with DLBCL (median 54 years [range, 21-76]; male:female, 50:53) were retrospectively reviewed. Skeletal muscle area at the third lumbar vertebral (L3) level was measured, and skeletal muscle index (SMI) was calculated to determine sarcopenia, defined as SMI < 44.77 cm2/m2 and < 32.50 cm2/m2 for male and female, respectively. Glucometabolic parameters of the psoas major muscle, including maximum standardized uptake value (SUVmax) and mean standardized uptake value (SUVmean), were measured at L3 as well. Their changes across treatment were also calculated as ΔSMI, ΔSUVmax, and ΔSUVmean; Δbody mass index was also calculated. Associations between SMI and the metabolic parameters were analyzed, and their associations with progression-free survival (PFS) and overall survival (OS) were identified. Results: The incidence of sarcopenia was 29.1% and 36.9% before and after treatment, respectively. SMI (P = 0.004) was lower, and sarcopenia was more frequent (P = 0.011) at end-of-treatment than at baseline. The SUVmax and SUVmean of muscle were lower (P < 0.001) in sarcopenia than in non-sarcopenia at both baseline and end-of-treatment. ΔSMI was positively correlated with ΔSUVmax of muscle (P = 0.022). Multivariable Cox regression analysis showed that sarcopenia at end-of-treatment was independently negatively associated with PFS (adjusted hazard ratio [95% confidence interval], 2.469 [1.022-5.965]), while sarcopenia at baseline was independently negatively associated with OS (5.051 [1.453-17.562]). Conclusion: Sarcopenic patients had lower muscle glucometabolism, and the muscular and metabolic changes across treatment were positively correlated. Sarcopenia at baseline and end-of-treatment was negatively associated with the prognosis of DLBCL.

Changes in Automated Mammographic Breast Density Can Predict Pathological Response After Neoadjuvant Chemotherapy in Breast Cancer

  • Jee Hyun Ahn;Jieon Go;Suk Jun Lee;Jee Ye Kim;Hyung Seok Park;Seung Il Kim;Byeong-Woo Park;Vivian Youngjean Park;Jung Hyun Yoon;Min Jung Kim;Seho Park
    • Korean Journal of Radiology
    • /
    • 제24권5호
    • /
    • pp.384-394
    • /
    • 2023
  • Objective: Mammographic density is an independent risk factor for breast cancer that can change after neoadjuvant chemotherapy (NCT). This study aimed to evaluate percent changes in volumetric breast density (ΔVbd%) before and after NCT measured automatically and determine its value as a predictive marker of pathological response to NCT. Materials and Methods: A total of 357 patients with breast cancer treated between January 2014 and December 2016 were included. An automated volumetric breast density (Vbd) measurement method was used to calculate Vbd on mammography before and after NCT. Patients were divided into three groups according to ΔVbd%, calculated as follows: Vbd (post-NCT - pre-NCT)/pre-NCT Vbd × 100 (%). The stable, decreased, and increased groups were defined as -20% ≤ ΔVbd% ≤ 20%, ΔVbd% < -20%, and ΔVbd% > 20%, respectively. Pathological complete response (pCR) was considered to be achieved after NCT if there was no evidence of invasive carcinoma in the breast or metastatic tumors in the axillary and regional lymph nodes on surgical pathology. The association between ΔVbd% grouping and pCR was analyzed using univariable and multivariable logistic regression analyses. Results: The interval between the pre-NCT and post-NCT mammograms ranged from 79 to 250 days (median, 170 days). In the multivariable analysis, ΔVbd% grouping (odds ratio for pCR of 0.420 [95% confidence interval, 0.195-0.905; P = 0.027] for the decreased group compared with the stable group), N stage at diagnosis, histologic grade, and breast cancer subtype were significantly associated with pCR. This tendency was more evident in the luminal B-like and triple-negative subtypes. Conclusion: ΔVbd% was associated with pCR in breast cancer after NCT, with the decreased group showing a lower rate of pCR than the stable group. Automated measurement of ΔVbd% may help predict the NCT response and prognosis in breast cancer.

Impact of Skeletal Muscle Loss and Visceral Obesity Measured Using Serial CT on the Prognosis of Operable Breast Cancers in Asian Patients

  • Mi-ri Kwon;Eun Sook Ko;Min Su Park;Woo Kyoung Jeong;Na Young Hwang;Jae-Hun Kim;Jeong Eon Lee;Seok Won Kim;Jong Han Yu;Boo-Kyung Han;Eun Young Ko;Ji Soo Choi;Ko Woon Park
    • Korean Journal of Radiology
    • /
    • 제23권2호
    • /
    • pp.159-171
    • /
    • 2022
  • Objective: This study aimed to investigate the impact of baseline values and temporal changes in body composition parameters, including skeletal muscle index (SMI) and visceral adipose tissue area (VAT), measured using serial computed tomography (CT) imaging on the prognosis of operable breast cancers in Asian patients. Materials and Methods: This study retrospectively included 627 Asian female (mean age ± standard deviation [SD], 53.6 ± 8.3 years) who underwent surgery for stage I-III breast cancer between January 2011 and September 2012. Body composition parameters, including SMI and VAT, were semi-automatically calculated on baseline abdominal CT at the time of diagnosis and follow-up CT for post-treatment surveillance. Serial changes in SMI and VAT were calculated as the delta values. Multivariable Cox regression analysis was used to evaluate the association of baseline and delta SMI and VAT values with disease-free survival. Results: Among 627 patients, 56 patients (9.2%) had breast cancer recurrence after a median of 40.5 months. The mean value ± SD of the baseline SMI and baseline VAT were 43.7 ± 5.8 cm2/m2 and 72.0 ± 46.0 cm2, respectively. The mean value of the delta SMI was -0.9 cm2/m2 and the delta VAT was 0.5 cm2. The baseline SMI and VAT were not significantly associated with disease-free survival (adjusted hazard ratio [HR], 0.983; 95% confidence interval [CI], 0.937-1.031; p = 0.475 and adjusted HR, 1.001; 95% CI, 0.995-1.006; p = 0.751, respectively). The delta SMI and VAT were also not significantly associated with disease-free survival (adjusted HR, 0.894; 95% CI, 0.766-1.043; p = 0.155 and adjusted HR, 1.001; 95% CI, 0.989-1.014; p = 0.848, respectively). Conclusion: Our study revealed that baseline and early temporal changes in SMI and VAT were not independent prognostic factors regarding disease-free survival in Asian patients undergoing surgery for breast cancer.

Technical Feasibility of Quantitative Measurement of Various Degrees of Small Bowel Motility Using Cine Magnetic Resonance Imaging

  • Ji Young Choi;Jihye Yun;Subin Heo;Dong Wook Kim;Sang Hyun Choi;Jiyoung Yoon;Kyuwon Kim;Kee Wook Jung;Seung-Jae Myung
    • Korean Journal of Radiology
    • /
    • 제24권11호
    • /
    • pp.1093-1101
    • /
    • 2023
  • Objective: Cine magnetic resonance imaging (MRI) has emerged as a noninvasive method to quantitatively assess bowel motility. However, its accuracy in measuring various degrees of small bowel motility has not been extensively evaluated. We aimed to draw a quantitative small bowel motility score from cine MRI and evaluate its performance in a population with varying degrees of small bowel motility. Materials and Methods: A total of 174 participants (28.5 ± 7.6 years; 135 males) underwent a 22-second-long cine MRI sequence (2-dimensional balanced turbo-field echo; 0.5 seconds per image) approximately 5 minutes after being intravenously administered 10 mg of scopolamine-N-butyl bromide to deliberately create diverse degrees of small bowel motility. In a manually segmented area of the small bowel, motility was automatically quantified using a nonrigid registration and calculated as a quantitative motility score. The mean value (MV) of motility grades visually assessed by two radiologists was used as a reference standard. The quantitative motility score's correlation (Spearman's ρ) with the reference standard and performance (area under the receiver operating characteristics curve [AUROC], sensitivity, and specificity) for diagnosing adynamic small bowel (MV of 1) were evaluated. Results: For the MV of the quantitative motility scores at grades 1, 1.5, 2, 2.5, and 3, the mean ± standard deviation values were 0.019 ± 0.003, 0.027 ± 0.010, 0.033 ± 0.008, 0.032 ± 0.009, and 0.043 ± 0.013, respectively. There was a significant positive correlation between the quantitative motility score and the MV (ρ = 0.531, P < 0.001). The AUROC value for diagnosing a MV of 1 (i.e., adynamic small bowel) was 0.953 (95% confidence interval, 0.923-0.984). Moreover, the optimal cutoff for the quantitative motility score was 0.024, with a sensitivity of 100% (15/15) and specificity of 89.9% (143/159). Conclusion: The quantitative motility score calculated from a cine MRI enables diagnosis of an adynamic small bowel, and potentially discerns various degrees of bowel motility.